Vânia Fernandes

Vânia Fernandes

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2023 in Life
Verified
Journal Article
Open access
PDF file
JPJoão Oliveira Pereira
João Oliveira Pereira
VFVânia Fernandes
Vânia Fernandes
TATiago Alfaro
Tiago Alfaro
SFSara Freitas
Sara Freitas
CCCarlos Robalo Cordeiro
Carlos Robalo Cordeiro
Hypersensitivity pneumonitis is a complex interstitial lung syndrome and is associated with significant morbimortality, particularly for fibrotic disease. This condition is characterized by sensitization to a specific antigen, whose early identification is associated with improved outcomes. Biomarkers measure objectively biologic processes and may support clinical decisions. These tools evolved to play a crucial role in the diagnosis and management of a wide range of human diseases. This is not the case, however, with hypersensitivity pneumonitis, where there is still great room for research in the path to find consensual diagnostic biomarkers. Gaps in the current evidence include lack of validation, validation against healthy controls alone, small sampling and heterogeneity in diagnostic and classification criteria. Furthermore, discriminatory accuracy is currently limited by overlapping mechanisms of inflammation, damage and fibrogenesis between ILDs. Still, biomarkers such as BAL lymphocyte counts and specific serum IgGs made their way into clinical guidelines, while others including KL-6, SP-D, YKL-40 and apolipoproteins have shown promising results in leading centers and have potential to translate into daily practice. As research proceeds, it is expected that the emergence of novel categories of biomarkers will offer new and thriving tools that could complement those currently available.

3 November 2025 in Acta Medica Portuguesa
Verified
Journal Article
Open access
COCláudia Pinto Oliveira
Cláudia Pinto Oliveira
MSMariana Pereira Silva
Mariana Pereira Silva
CVCarolina Vilafanha
Carolina Vilafanha
GCGraça Costa
Graça Costa
MSMariana Emília Santos
Mariana Emília Santos
Eduardo DouradoEduardo Dourado
Eduardo Dourado
Idiopathic inflammatory myopathies (IIM) are a heterogeneous group of systemic autoimmune rheumatic disorders in which chronic inflammation of skeletal muscle leads to muscle weakness. Many other organs, including the skin, heart, lungs, and joints, may be affected. Patients with IIM may be positive for myositis antibodies (MAs), including myositis-specific and/or associated antibodies. Although helpful for establishing the diagnosis of IIM in the appropriate clinical setting, the presence of MAs does not always predict the occurrence of connective tissue diseases. Additionally, commonly used techniques such as line blot are known to have high rates of false positivity, especially for rare MAs. The accuracy of MAs tests such as line blot may be improved by cross-checking their results with antinuclear antibody (ANA) patterns on HEp-2 indirect immunofluorescence (IIF). This study aims to examine the concordance between ANA IIF patterns and myositis-specific antibodies in a Portuguese cohort of patients with IIM. We will assess whether concordance between methods is associated with increased fulfillment of IIM classification criteria, greater disease severity, or distinct patterns of organ involvement among affected patients.

7 September 2020 in European Respiratory Journal
Verified
Conference Paper
Closed access
VFVânia Fernandes
Vânia Fernandes
JPJ P Pereira
J P Pereira
TAT M Alfaro
T M Alfaro
AFA J Ferreira
A J Ferreira
CCC R Cordeiro
C R Cordeiro
Introduction: Esophageal cancer (EC) causes high morbidity and mortality. Flexible bronchoscopy (FB) is useful for diagnosis, staging, and planning endoscopic intervention. We aimed to analyze the bronchoscopic characteristics of EC patients at the time of diagnosis, and its correlation with staging and mortality. Methods: Retrospective review of patients with a recent diagnosis of EC submitted to FB in our centre between 2006 and 2019. Results: we included 112 patients, with a median age of 64 years (41-96), 90.2% were male (n=102). 90% (n=101) had squamous cell carcinoma, 6.3% adenocarcinoma (n=7) and 3.6% undifferentiated carcinoma (n=4). Of squamous cell, 11.6% were stage II, 11.6% III, 30.4% IVA, 33.9% IVB and 6.3% unknown. Those with adenocarcinoma had stage III (n=1), IVA (n=2), IVB (n=3) or unknown (n=1). In 92.9% FB was performed after diagnosis (median of 27.5±59.8 days). 53.6% (n=60) had normal FB, 25.9% (n=29) had extrinsic compression and 20.5% (n=23) had tracheal/bronchial invasion, with fistula in 3. Invasion occurred mainly in proximal (17%, n=19), or middle trachea (7.1%, n=8). Invasion was associated with Stage IV (p<0.001), and with increased mortality, regardless of histology and stage (p<0.001). Treatment included chemo-radiotherapy in 26.8%, chemotherapy in 20.5%, neoadjuvant chemo-radiotherapy plus surgery in 14.3%, radiotherapy in 9.8%, surgery plus adjuvant chemo-radiotherapy in 0.9% and supportive care in 25%. The overall survival was 60.5% at 6 months and 40.1% at 12 months. Conclusion: FB is important for initial evaluation of EC patients, and is useful for prognosis, especially when there is invasion. It also identifies patients who benefit from endoscopic treatment, improving quality of life.

10 September 2026 in ERJ Open Research
Verified
Journal Article
Open access
AGAna Sofia Grave
Ana Sofia Grave
CDCíntia Dias
Cíntia Dias
VFVânia Fernandes
Vânia Fernandes
SBSurinder S. Birring
Surinder S. Birring
DTDiogo Tecelão
Diogo Tecelão
AOAna Oliveira
Ana Oliveira
A validated tool to assess cough hypersensitivity in European Portuguese speakers with chronic respiratory diseases (CRD) and chronic cough (CC) is currently lacking. This study aimed to translate, culturally adapt, and explore the measurement properties of the European Portuguese version of the Cough Hypersensitivity Questionnaire (CHQ-PT) in chronic cough associated with CRD. This two-phased study included: (1) translation and cultural adaptation, and (2) measurement properties evaluation. Internal consistency (Cronbach's α), test-retest reliability, inter-rater (between different assessors) reliability (intraclass correlation coefficient 95% confidence intervals-ICC 3,1 [95%CI] and ICC 2,1 [95%CI]), agreement (standard error of measurement-[ sem ], minimal detectable change 95% confidence level [MDC 95 ]), floor/ceiling effects, and construct validity (convergent/divergent – Pearson correlation coefficient[r]/Spearman's[ρ]) were evaluated. Two forward/back-translations and cognitive debriefing (n=8) were conducted. Fifty-two participants (48% women, 66±12 years, 72% interstitial lung disease) were included. Internal consistency was good for the CHQ-PT total score (α=0.80). Test-retest reliability of the total score was good (ICC 3,1 =0.85[0.76;0.91]) with acceptable measurement error ( sem =1.89; MDC 95 =5.24). Inter-rater reliability was also good (ICC=0.80 [0.66–0.89) No floor/ceiling effects were found. Construct validity was supported by moderate correlations with cough-related quality of life (ρ=-0.52), dyspnoea (ρ=0.43), and fatigue (r=-0.55). Domain-level analyses showed lower repeatability for the laryngeal sensations’ domain (ICC 3,1 =0.65[0.47;0.78]; ICC 2,1 =0.43[0.18;0.63]). The CHQ-PT is a reliable and valid instrument for assessing cough hypersensitivity in European Portuguese individuals with CRD and CC.

8 November 2026 in Family Relations
Verified
Journal Article
Closed access
RMRaquel Vilar Marinho
Raquel Vilar Marinho
SCSérgio Campainha
Sérgio Campainha
ETEduarda Milheiro Tinoco
Eduarda Milheiro Tinoco
TSTeresa Shiang
Teresa Shiang
ESEloísa Silva
Eloísa Silva
AMAlda Marques
Alda Marques

26 May 2025 in Monaldi Archives for Chest Disease
Verified
Journal Article
Open access
PDF file
FFFlávia Ferreira
Flávia Ferreira
AMAna Machado
Ana Machado
VFVânia Fernandes
Vânia Fernandes
TATiago Alfaro
Tiago Alfaro
AMAlda Marques
Alda Marques
AOAna Oliveira
Ana Oliveira
Dear Editor,Chronic cough, lasting at least 8 weeks, is a prevalent symptom in individuals with interstitial lung disease, posing significant physical, psychological, and social challenges....